Acadia Pharmaceuticals | ACAD - Capitalizzazione Di Mercato





Capitalizzazione Di Mercato Cambiamento Data
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
ALKERMES USD 8.73B 2.85B 2026-06
Alnylam Pharmaceuticals USD 22.44B 10.57B 2026-10
Biogen USD 35.56B 2.19B 2026-10
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 124.51B 2.96B 2026-10
Cara Therapeutics USD 30M 336M 2026-03
Corcept Therapeutics USD 9.33B 5.02B 2026-06
Cytokinetics USD 11.55B 3.36B 2026-06
Eisai JPY 1.2T 219.32B 2026-06
Eli Lilly USD 1.31T 216.84B 2026-10
Incyte USD 26.22B 1.63B 2026-10
J&J USD 607B 46.61B 2026-10
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Prothena USD 516M 2M 2026-03
PTC Therapeutics USD 4.94B 1.86B 2026-10
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06